0.9509
price down icon13.55%   -0.1491
 
loading
Accendra Health Inc stock is traded at $0.9509, with a volume of 2.87M. It is down -13.55% in the last 24 hours and down -73.66% over the past month. Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
See More
Previous Close:
$1.10
Open:
$1.08
24h Volume:
2.87M
Relative Volume:
2.95
Market Cap:
$73.13M
Revenue:
$4.72B
Net Income/Loss:
$-123.85M
P/E Ratio:
-0.0665
EPS:
-14.2981
Net Cash Flow:
$-303.12M
1W Performance:
-66.04%
1M Performance:
-73.66%
6M Performance:
-57.55%
1Y Performance:
-82.02%
1-Day Range:
Value
$0.9337
$1.09
1-Week Range:
Value
$0.9337
$1.74
52-Week Range:
Value
$0.9337
$4.6887

Accendra Health Inc Stock (ACH) Company Profile

Name
Name
Accendra Health Inc
Name
Phone
(804) 277-4304
Name
Address
4435 WATERFRONT DRIVE, GLEN ALLEN
Name
Employee
6,500
Name
Twitter
Name
Next Earnings Date
2026-08-10
Name
Latest SEC Filings
Name
ACH's Discussions on Twitter

Compare ACH vs MCK, COR, CAH, HSIC, AHG

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
ACH icon
ACH
Accendra Health Inc
0.9509 93.05M 4.72B -123.85M -303.12M -14.30
MCK icon
MCK
Mckesson Corp
869.00 102.45B 403.43B 5.10B 5.41B 38.47
COR icon
COR
Cencora Inc
313.82 59.95B 328.68B 2.55B 1.56B 13.03
CAH icon
CAH
Cardinal Health Inc
235.17 54.46B 250.74B 1.55B 4.39B 6.5398
HSIC icon
HSIC
Henry Schein Inc
89.77 10.11B 13.38B 418.00M 391.00M 3.3112
AHG icon
AHG
Akso Health Group Adr
1.27 1.26B 14.85M -136.07M 7.25M -0.4726

Accendra Health Inc Stock (ACH) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-03-25 Downgrade UBS Buy → Neutral
Jul-19-24 Upgrade Citigroup Neutral → Buy
Feb-26-24 Initiated Leerink Partners Market Perform
Jan-03-24 Initiated Barclays Equal Weight
Oct-13-22 Downgrade Citigroup Buy → Neutral
Oct-12-22 Downgrade BofA Securities Buy → Underperform
Oct-12-22 Downgrade Robert W. Baird Outperform → Neutral
Apr-26-22 Resumed Citigroup Buy
Apr-01-22 Resumed Credit Suisse Neutral
Mar-30-22 Resumed JP Morgan Underweight
Mar-23-22 Upgrade HSBC Securities Reduce → Hold
Apr-08-21 Upgrade JP Morgan Neutral → Overweight
Mar-08-21 Upgrade Goldman Sell → Buy
Dec-17-20 Upgrade UBS Neutral → Buy
Sep-25-20 Upgrade Barclays Underweight → Equal Weight
Jul-21-20 Upgrade BofA Securities Neutral → Buy
Jul-21-20 Upgrade Robert W. Baird Neutral → Outperform
Jul-14-20 Upgrade Credit Suisse Neutral → Outperform
May-05-20 Downgrade Robert W. Baird Outperform → Neutral
Apr-23-20 Resumed Credit Suisse Neutral
Jan-21-20 Upgrade Robert W. Baird Neutral → Outperform
Jan-07-20 Downgrade Goldman Neutral → Sell
Nov-15-19 Upgrade CLSA Underperform → Outperform
Sep-06-19 Reiterated BofA/Merrill Neutral
Apr-10-19 Reiterated BofA/Merrill Neutral
Apr-03-19 Upgrade BofA/Merrill Neutral → Buy
Apr-01-19 Upgrade JP Morgan Underweight → Overweight
Jan-18-19 Upgrade HSBC Securities Hold → Buy
Jan-17-19 Initiated UBS Neutral
Jan-15-19 Upgrade CLSA Underperform → Outperform
Dec-14-18 Downgrade Morgan Stanley Overweight → Underweight
Dec-12-18 Downgrade Goldman Buy → Neutral
Sep-28-18 Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-11-18 Downgrade CLSA Outperform → Sell
Apr-10-18 Upgrade Credit Suisse Neutral → Outperform
Mar-26-18 Upgrade Goldman Sell → Neutral
Nov-02-17 Downgrade HSBC Securities Buy → Hold
Mar-24-16 Upgrade Goldman Sell → Neutral
Dec-07-15 Downgrade Goldman Neutral → Sell
Aug-31-15 Upgrade Credit Suisse Underperform → Neutral
Aug-01-12 Initiated HSBC Securities Underweight
Aug-05-09 Upgrade Citigroup Sell → Buy
Dec-01-08 Downgrade HSBC Securities Neutral → Underweight
View All

Accendra Health Inc Stock (ACH) Latest News

pulisher
Aug 14, 2026

Accendra Health ready to put weak Q2 in rear view - HME News

Aug 14, 2026
pulisher
Aug 14, 2026

Accendra Health Inc (NYSE: ACH) Share Price, ACH Stock News, ACH Share Price & Updates - Kalkine

Aug 14, 2026
pulisher
Aug 12, 2026

Accendra Health (NYSE:ACH) Rating Lowered to "Hold" at Robert W. Baird - MarketBeat

Aug 12, 2026
pulisher
Aug 12, 2026

Dimensional Fund Advisors LP Buys Shares of 2,606,620 Accendra Health, Inc. $ACH - MarketBeat

Aug 12, 2026
pulisher
Aug 11, 2026

Accendra Health, Inc. (ACH) stock price, news, quote and history - Yahoo Finance UK

Aug 11, 2026
pulisher
Aug 11, 2026

Baird downgrades Accendra Health stock rating on weak results By Investing.com - Investing.com South Africa

Aug 11, 2026
pulisher
Aug 11, 2026

Accendra Health, Inc. (ACH) Stock Price, News, Quote & History - Yahoo! Finance Canada

Aug 11, 2026
pulisher
Aug 11, 2026

Baird Downgrades Accendra Health to Neutral From Outperform, Adjusts PT to $1.50 From $6 - marketscreener.com

Aug 11, 2026
pulisher
Aug 11, 2026

ACCENDRA HEALTH INC : BAIRD CUTS TO NEUTRAL RATING; CUTS TARGET PRICE TO $1.5 FROM $6 - Bitget

Aug 11, 2026
pulisher
Aug 11, 2026

Baird downgrades Accendra Health stock rating on weak results - Investing.com

Aug 11, 2026
pulisher
Aug 11, 2026

Accendra Health Chief Executive Edward Pesicka to Retire - Moomoo

Aug 11, 2026
pulisher
Aug 11, 2026

Accendra Health Ord Shs (ACH) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com

Aug 11, 2026
pulisher
Aug 10, 2026

Accendra Health tumbles 25% on Q2 miss and weak guidance By Investing.com - Investing.com UK

Aug 10, 2026
pulisher
Aug 10, 2026

Accendra Health, Inc. (ACH) Stock Forecasts - Yahoo Finance

Aug 10, 2026
pulisher
Aug 10, 2026

Accendra Health Reports 111.1% Wider Q2 2026 Loss at -$0.19/Share - AlphaStreet

Aug 10, 2026
pulisher
Aug 10, 2026

Accendra Health Releases Q2 2026 Financial Results - AlphaStreet

Aug 10, 2026
pulisher
Aug 10, 2026

Accendra Health says Q2 2026 results miss forecast on weaker revenue growth, slower collections recovery - Bitget

Aug 10, 2026
pulisher
Aug 10, 2026

Accendra Health, Inc. Updates Earnings Guidance for the Full Year 2026 - marketscreener.com

Aug 10, 2026
pulisher
Aug 10, 2026

Accendra Health seeks next president, CEO - HME News

Aug 10, 2026
pulisher
Aug 10, 2026

ACCENDRA HEALTH 2026: Revenue $613.23M, EPS ($1.16) — 10-Q Summary - TradingView

Aug 10, 2026
pulisher
Aug 10, 2026

Accendra Health: Expansion opportunities will emerge later in 2026, accelerate in 2027 - HME News

Aug 10, 2026
pulisher
Aug 10, 2026

Accendra Health CEO to retire by end of the year - Virginia Business

Aug 10, 2026
pulisher
Aug 10, 2026

Earnings call transcript: Accendra Health cuts 2026 outlook as shares sink in Q2 2026 - Investing.com

Aug 10, 2026
pulisher
Aug 10, 2026

Accendra Health tumbles 25% on Q2 miss and weak guidance - Investing.com

Aug 10, 2026
pulisher
Aug 10, 2026

Accendra Health, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:ACH) 2026-08-10 - Seeking Alpha

Aug 10, 2026
pulisher
Aug 10, 2026

Q2 2026 Accendra Health Inc Earnings Call Transcript - GuruFocus

Aug 10, 2026
pulisher
Aug 10, 2026

Edward A. Pesicka Plans to Retire as Chief Executive Officer of Accendra Health, Inc - marketscreener.com

Aug 10, 2026
pulisher
Aug 10, 2026

Is Accendra Health Inc (ACH) Undervalued After Q2 Earnings Miss? EPS: -$1.16, Revenue: $613.2M; GF Score: 52/100 - GuruFocus

Aug 10, 2026
pulisher
Aug 10, 2026

Accendra Health CEO Edward Pesicka to retire by end of 2026 - Investing.com Australia

Aug 10, 2026
pulisher
Aug 10, 2026

Accendra Health CEO Ed Pesicka Plans Retirement as Board Begins Successor Search - citybiz

Aug 10, 2026
pulisher
Aug 10, 2026

Accendra Health adopts plan to preserve tax loss carryforwards - Investing.com India

Aug 10, 2026
pulisher
Aug 10, 2026

Accendra Health adopts plan to preserve tax loss carryforwards By Investing.com - Investing.com Canada

Aug 10, 2026
pulisher
Aug 10, 2026

Accendra Health Q2 Revenue Falls to $613.2 Million - quiverquant.com

Aug 10, 2026
pulisher
Aug 10, 2026

Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value - Business Wire

Aug 10, 2026
pulisher
Aug 10, 2026

BRIEF-Accendra Health, Inc Q2 Adjusted EBITDA USD 60.1 Million Vs. IBES Estimate USD 61.3 Million - TradingView

Aug 10, 2026
pulisher
Aug 10, 2026

Press Release: Accendra Health Reports Second Quarter 2026 Financial Results - Moomoo

Aug 10, 2026
pulisher
Aug 10, 2026

Accendra Health’s Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search - Post Register

Aug 10, 2026
pulisher
Aug 10, 2026

Accendra Health Q2 2026 slides: revenue falls, debt cut $370M - Investing.com Nigeria

Aug 10, 2026
pulisher
Aug 07, 2026

Accendra Health Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView

Aug 07, 2026
pulisher
Aug 05, 2026

Accendra Health Q2 Preview: Low Expectations Create Opportunity (NYSE:ACH) - Seeking Alpha

Aug 05, 2026
pulisher
Aug 03, 2026

Weekly Recap: Q2 2026 results and Agnes Ansay named VP and CPO - TradingView

Aug 03, 2026
pulisher
Aug 01, 2026

Enterprise value to EBITDA forward of Accendra Health, Inc. – NYSE:ACH - TradingView

Aug 01, 2026
pulisher
Aug 01, 2026

Accendra Health, Inc. Revenue Breakdown – NYSE:ACH - TradingView

Aug 01, 2026
pulisher
Jul 27, 2026

ACH|Accendra Health Ord Shs|Price:3.215|Chg%:+0.075 - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Accendra Health names new CIO and chief procurement officer - Investing.com

Jul 27, 2026
pulisher
Jul 27, 2026

Accendra Health Announces Leadership Appointments in IT and Procurement - Business Wire

Jul 27, 2026
pulisher
Jul 27, 2026

Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call - Business Wire

Jul 27, 2026
pulisher
Jul 27, 2026

Accendra Health Ord Shs (ACH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

Accendra Health Inc. (ACH) Edges Higher Amid Steady Sector Sentiment – Key Levels in FocusHigh Volume Node - po-news-eg.net

Jul 26, 2026
pulisher
Jul 26, 2026

ACH|Accendra Health Ord Shs|Price:2.945|Chg%:-0.465 - tradingkey.com

Jul 26, 2026
pulisher
Jul 25, 2026

Paradigm Capital Management Inc. NY Purchases New Position in Accendra Health, Inc. $ACH - MarketBeat

Jul 25, 2026

Accendra Health Inc Stock (ACH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
YI YI
$3.67
price down icon 3.42%
$0.2179
price up icon 5.52%
$0.4199
price down icon 0.02%
$4.76
price up icon 2.81%
AHG AHG
$1.27
price down icon 2.31%
Cap:     |  Volume (24h):